Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review

References

• Barr IG, McCauley J, Cox N, et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 2009;28:1156-67
   PubMed Web of Science ®Google Scholar
• Wood JM, Levandowski RA. The influenza vaccine licensing process. Vaccine 2003;21:1786-8
   PubMed Web of Science ®Google Scholar
• Smith PG, Rodrigues LC, Fine PE. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol 1984;13:87-93
   PubMed Web of Science ®Google Scholar
• Jackson LA, Jackson ML, Nelson JC, et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006;35:337-44
   PubMed Web of Science ®Google Scholar
• Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013;31:3104-9
   PubMed Web of Science ®Google Scholar
• Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013;31:2165-8
   PubMed Web of Science ®Google Scholar
• Orenstein EW, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007;36:623-31
   PubMed Web of Science ®Google Scholar
• De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Vaccine 2013;18
   Google Scholar
• CIDRAP. Available from: www.cidrap.umn.edu
   Google Scholar
• Poole C, Greenland S. Random-effects meta-analyses are not always conservative. Am J Epidemiol 1999;150:469-75
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat med 2002;21:1539-58
   PubMed Web of Science ®Google Scholar
• Amour S, Voirin N, Regis C, et al. Influenza vaccine effectiveness among adult patients in a University of Lyon hospital (2004-2009). Vaccine 2012;30:821-4
   PubMed Web of Science ®Google Scholar
• Andrews N, McMenamin J, Durnall H, et al. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Euro Surveill 2014;19:5-13
   PubMedGoogle Scholar
• Andrews N, Waight P, Yung CF, Miller E. Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. J Infect Dis 2011;203:32-9
   PubMed Web of Science ®Google Scholar
• Barret AS, Donnell JO, O’Hora A, et al. Effectiveness of 2010/2011 seasonal influenza vaccine in Ireland. Irish Med J 2012;105:39-42
   PubMedGoogle Scholar
• Bateman AC, Kieke BA, Irving SA, et al. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season. J Infect Dis 2013;207:1262-9
   PubMed Web of Science ®Google Scholar
• Belongia EA, Kieke BA, Donahue JG, et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine 2011;29:6558-63
   PubMed Web of Science ®Google Scholar
• Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009;199:159-67
   PubMed Web of Science ®Google Scholar
• Blyth CC, Jacoby P, Effler PV, et al. Effectiveness of Trivalent Flu Vaccine in Healthy Young Children. Pediatrics 2014; 32:4075-81
   Google Scholar
• Castilla J, Martinez-Artola V, Salcedo E, et al. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study. Vaccine 2012;30:195-200
   PubMed Web of Science ®Google Scholar
• Castilla J, Martinez-Baz I, Martinez-Artola V, et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013;18 pii=20388
   Google Scholar
• Castilla J, Moran J, Martinez-Artola V, et al. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. Vaccine 2011;29:5919-24
   PubMed Web of Science ®Google Scholar
• Cheng AC, Flu CANI. Hospitalisation with confirmed influenza in a sentinel surveillance system in 2010 and 2011. Med J Aust 2012;197:217
   PubMed Web of Science ®Google Scholar
• Cheng AC, Kotsimbos T, Kelly HA, et al. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study. Vaccine 2011;29:7320-5
   PubMed Web of Science ®Google Scholar
• Coleman LA, Kieke B, Irving S, et al. Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR). Vaccine 2011;29:387-90
   PubMed Web of Science ®Google Scholar
• Cowling BJ, Chan KH, Feng S, et al. The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013. Vaccine 2014;32:5278-84
   PubMed Web of Science ®Google Scholar
• Dawood FS, Prapasiri P, Areerat P, et al. Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged >/= 50 years. Influenza Other Respir Vir 2014;8:463-8
   PubMed Web of Science ®Google Scholar
• Eick-Cost AA, Tastad KJ, Guerrero AC, et al. Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach. PLoS One 2012;7:e41435
   PubMed Web of Science ®Google Scholar
• Eisenberg KW, Szilagyi PG, Fairbrother G, et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008;122:911-19
   PubMed Web of Science ®Google Scholar
• Englund H, Campe H, Hautmann W. Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season. Epidemiol Infect 2013;141:1807-15
   PubMed Web of Science ®Google Scholar
• Ferdinands JM, Olsho LE, Agan AA, et al. Effectiveness of Influenza Vaccine Against Life-threatening RT-PCR-confirmed Influenza Illness in US Children, 2010-2012. J Infect Dis 2014;210(5):674-83
   PubMed Web of Science ®Google Scholar
• Fielding J, Grant K, Tran T, Kelly H. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. Euro Surveill 2012;17: pii=20115. Epub 15 March 2012
   PubMedGoogle Scholar
• Fielding JE, Grant KA, Garcia K, Kelly HA. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010. Emerg Infect Dis 2011;17:1181-7
   PubMed Web of Science ®Google Scholar
• Fielding JE, Grant KA, Papadakis G, Kelly HA. Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008. BMC Infect Dis 2011;11:170
   PubMed Web of Science ®Google Scholar
• Fleming DM, Andrews NJ, Ellis JS, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health 2010;64:1062-7
   PubMed Web of Science ®Google Scholar
• Gefenaite G, Rahamat-Langendoen J, Ambrozaitis A, et al. Seasonal influenza vaccine effectiveness against influenza in 2012-2013: a hospital-based case-control study in Lithuania. Vaccine 2014;32:857-63
   PubMed Web of Science ®Google Scholar
• Griffin MR, Monto AS, Belongia EA, et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011;6:e23085
   PubMed Web of Science ®Google Scholar
• Hardelid P, Fleming DM, McMenamin J, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill 2011;16
   Google Scholar
• Hellenbrand W, Jorgensen P, Schweiger B, et al. Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls. BMC Infect Dis 2012;12:127
   PubMed Web of Science ®Google Scholar
• Ho HP, Zhao X, Pang J, et al. Effectiveness of seasonal influenza vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel in 2010-2013. Influenza Other Respir Viruses 2014;8(5):557-66
   PubMed Web of Science ®Google Scholar
• Janjua NZ, Skowronski DM, De Serres G, et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada’s sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis 2012;205:1858-68
   PubMed Web of Science ®Google Scholar
• Jefferies S, Earl D, Berry N, et al. Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A(H1N1)2009 in healthcare workers in New Zealand, June-August 2009. Euro Surveill 2011;16
   PubMedGoogle Scholar
• Jimenez-Jorge S, de Mateo S, Delgado-Sanz C, et al. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination. BMC Infect Dis 2013;13:441
   PubMed Web of Science ®Google Scholar
• Jimenez-Jorge S, Savulescu C, Pozo F, et al. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine 2012;30:3595-602
   PubMed Web of Science ®Google Scholar
• Kafatos G, Pebody R, Andrews N, et al. Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study. Influenza Other Respir Viruses 2013;7:1175-80
   PubMed Web of Science ®Google Scholar
• Kelly H, Carville K, Grant K, et al. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 2009;4:e5079
   PubMed Web of Science ®Google Scholar
• Kelly H, Jacoby P, Dixon GA, et al. Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children: a Case-Control Study. Pediatr Infect Dis J 2011;30:107-11
   PubMed Web of Science ®Google Scholar
• Kelly HA, Grant KA, Fielding JE, et al. Pandemic influenza H1N1 2009 infection in Victoria, Australia: No evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. Vaccine 2011;29:6419-26
   PubMed Web of Science ®Google Scholar
• Kissling E, Valenciano M, Buchholz U, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill 2014;19
   PubMedGoogle Scholar
• Kissling E, Valenciano M, Cohen JM, et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One 2011;6:e27622
   PubMed Web of Science ®Google Scholar
• Kissling E, Valenciano M, Falcao J, et al. “I-MOVE” towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill 2009;14
   Google Scholar
• Kissling E, Valenciano M, Larrauri A, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 2013;18: pii=20390
   Google Scholar
• Kwong JC, Campitelli MA, Gubbay JB, et al. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis 2013;57:820-7
   PubMed Web of Science ®Google Scholar
• Larrauri A, Savulescu C, Jimenez-Jorge S, et al. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain. Gac Sanit 2011;25:23-8
   PubMed Web of Science ®Google Scholar
• Lo YC, Chuang JH, Kuo HW, et al. Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season. PLoS One 2013;8:e58222
   PubMed Web of Science ®Google Scholar
• Mahmud S, Hammond G, Elliott L, et al. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study. Vaccine 2011;29:7975-81
   PubMed Web of Science ®Google Scholar
• Mahmud SM, Van Caeseele P, Hammond G, et al. No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009. Emerg Infect Dis 2012;18:801-10
   PubMed Web of Science ®Google Scholar
• Martinez-Baz I, Martinez-Artola V, Reina G, et al. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study. BMC Public Health 2013;13:191
   PubMed Web of Science ®Google Scholar
• Menniti-Ippolito F, Da Cas R, Traversa G, et al. Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy. Vaccine 2014;32:4466-70
   PubMed Web of Science ®Google Scholar
• Nunes B, Machado A, Guiomar R, et al. Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups. Vaccine 2014;32:4443-9
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013;56:1363-9
   PubMed Web of Science ®Google Scholar
• Ortqvist A, Bennet R, Rinder MR, et al. Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza. Vaccine 2012;30:5699-702
   PubMed Web of Science ®Google Scholar
• Pebody R, Andrews N, McMenamin J, et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill 2013;18
   Google Scholar
• Pebody R, Andrews N, Waight P, et al. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. Vaccine 2011;29:2613-18
   PubMed Web of Science ®Google Scholar
• Pebody R, Hardelid P, Fleming D, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill 2011;16
   Google Scholar
• Puig-Barberà J, Arnedo-Pena A, Pardo-Serrano F, et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital-based, case-control study. Vaccine 2010;28:7460-7
   PubMed Web of Science ®Google Scholar
• Puig-Barbera J, Diez-Domingo J, Arnedo-Pena A, et al. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study. Vaccine 2012;30:5714-20
   PubMed Web of Science ®Google Scholar
• Puig-Barbera J, Natividad-Sancho A, Launay O, et al. 2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: results from the Global Influenza Hospital Surveillance Network. PLoS One 2014;9:e100497
   PubMed Web of Science ®Google Scholar
• Rondy M, Puig-Barbera J, Launay O, et al. 2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study. PLoS One 2013;8:e59681
   PubMed Web of Science ®Google Scholar
• Savulescu C, Jimenez-Jorge S, de Mateo S, et al. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. BMC Public Health 2011;11:899
   PubMed Web of Science ®Google Scholar
• Savulescu C, Jimenez-Jorge S, Delgado-Sanz C, et al. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011. Vaccine 2014;32:4404-11
   PubMed Web of Science ®Google Scholar
• Savulescu C, Valenciano M, de Mateo S, Larrauri A. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network – pilot case-control studies using different control groups, 2008-2009 season, Spain. Vaccine 2010;28:2903-7
   PubMed Web of Science ®Google Scholar
• Skowronski D, Gilbert M, Tweed S, et al. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004–2005. Can Commun Dis Rep 2005;31:181-91
   PubMedGoogle Scholar
• Skowronski DM, De Serres G, Crowcroft NS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010;7:e1000258
   PubMed Web of Science ®Google Scholar
• Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009;199:168-79
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Janjua NZ, De Serres G, et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ 2011;342:c7297
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Janjua NZ, De Serres G, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 season. Clin Infect Dis 2012;55:332-42
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Janjua NZ, Sabaiduc S, et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis 2014;210(1):126-37
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Masaro C, Kwindt TL, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007;25:2842-51
   PubMed Web of Science ®Google Scholar
• Song JY, Cheong HJ, Heo JY, et al. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. Vaccine 2011;29:1395-8
   PubMed Web of Science ®Google Scholar
• Staat MA, Griffin MR, Donauer S, et al. Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007. Vaccine 2011;29:9005-11
   PubMed Web of Science ®Google Scholar
• Sullivan SG, Chilver MB, Higgins G, et al. Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network. Med J Aust 2014;201:109-11
   PubMed Web of Science ®Google Scholar
• Sullivan SG, Komadina N, Grant K, et al. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match. J Med Virol 2014;86:1017-25
   PubMed Web of Science ®Google Scholar
• Sundaram ME, McClure DL, VanWormer JJ, et al. Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness. Clin Infect Dis 2013;57:789-93
   PubMed Web of Science ®Google Scholar
• Suzuki M, Minh le N, Yoshimine H, et al. Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011-2012 Season. PLoS One 2014;9:e88813
   PubMed Web of Science ®Google Scholar
• Suzuki M, Yoshimine H, Harada Y, et al. Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan. PLoS One 2013;8:e52103
   PubMed Web of Science ®Google Scholar
• Talbot HK, Griffin MR, Chen Q, et al. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis 2011;203:500-8
   PubMed Web of Science ®Google Scholar
• Talbot HK, Zhu Y, Chen Q, et al. Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season. Clin Infect Dis 2013;56:1774-7
   PubMed Web of Science ®Google Scholar
• Thompson MG, Li DK, Shifflett P, et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis 2014;58:449-57
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012;55:951-9
   PubMed Web of Science ®Google Scholar
• Turner N, Pierse N, Bissielo A, et al. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. Vaccine 2014;32:3687-93
   PubMed Web of Science ®Google Scholar
• Uphoff H, An der Heiden M, Schweiger B, et al. Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009 – a comparison of two methods; Germany, 2009/10. PLoS One 2011;6:e19932
   PubMed Web of Science ®Google Scholar
• Valenciano M, Kissling E, Cohen JM, et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med 2011;8:e1000388
   PubMed Web of Science ®Google Scholar
• Van Buynder PG, Dhaliwal JK, Van Buynder JL, et al. Protective effect of single-dose adjuvanted pandemic influenza vaccine in children. Influenza Other Respir Viruses 2010;4:171-8
   PubMed Web of Science ®Google Scholar
• Van Buynder PG, Konrad S, Van Buynder JL, et al. The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine 2013;31:6122-8
   PubMed Web of Science ®Google Scholar
• Yang P, Thompson MG, Ma C, et al. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China. Vaccine 2014;32:5285-9
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014;58:319-27
   PubMed Web of Science ®Google Scholar
• Nicol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. Wiley & Sons Inc; Malden, MA, USA: 1998. p. 359-72
   Google Scholar
• Sullivan SG, Tay EL, Kelly H. Variable definitions of the influenza season and their impact on vaccine effectiveness estimates. Vaccine 2013;31:4280-3
   PubMed Web of Science ®Google Scholar
• Sullivan SG, Komadina N, Grant K, et al. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: Influences of waning immunity and vaccine match. J Med Virol 2014;86(6):1017-25
   PubMed Web of Science ®Google Scholar
• Covalciuc KA, Webb KH, Carlson CA. Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (FLU OIA test) and cell culture methods. J Clin Microbiol 1999;37:3971-4
   PubMed Web of Science ®Google Scholar
• Lambert SB, Whiley DM, O’Neill NT, et al. Comparing nose-throat swabs and nasopharyngeal aspirates collected from children with symptoms for respiratory virus identification using real-time polymerase chain reaction. Pediatrics 2008;122:e615-20
   PubMed Web of Science ®Google Scholar
• Chan KH, Peiris JS, Lim W, et al. Comparison of nasopharyngeal flocked swabs and aspirates for rapid diagnosis of respiratory viruses in children. J Clin Virol 2008;42:65-9
   PubMed Web of Science ®Google Scholar
• Sung RY, Chan PK, Choi KC, et al. Comparative study of nasopharyngeal aspirate and nasal swab specimens for diagnosis of acute viral respiratory infection. J Clin Microbiol 2008;46:3073-6
   PubMed Web of Science ®Google Scholar
• Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008;167:775-85
   PubMed Web of Science ®Google Scholar
• Lau LL, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010;201:1509-16
   PubMed Web of Science ®Google Scholar
• Pebody RG, Andrews N, Fleming DM, et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiol Infect 2013;141(3):620-30
   PubMed Web of Science ®Google Scholar
• Sundaram ME, Meece JK, Sifakis F, et al. Medically attended respiratory syncytial virus infections in adults aged >/= 50 years: clinical characteristics and outcomes. Clin Infect Dis 2014;58:342-9
   PubMed Web of Science ®Google Scholar
• Suzuki T, Ono Y, Maeda H, et al. Effectiveness of trivalent influenza vaccine among children in two consecutive seasons in a community in Japan. Tohoku J Exp Med 2014;232:97-104
   PubMed Web of Science ®Google Scholar
• Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 2009;20:488-95
   PubMed Web of Science ®Google Scholar
• VanderWeele TJ. On the relative nature of overadjustment and unnecessary adjustment. Epidemiology 2009;20:496-9
   PubMed Web of Science ®Google Scholar
• Weinberg GA, Erdman DD, Edwards KM, et al. Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis 2004;189:706-10
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for influenza at CDC Atlanta. CDC protocol of real-time RT-PCR for influenza A(H1N1). WHO, Geneva, Switzerland; 2009. Available from: www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/
   Google Scholar
• Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med 2002;21:2409-19
   PubMed Web of Science ®Google Scholar
• Sullivan SG, Kelly H. Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007-2012. Euro Surveill 2013;18: pii=20605
   PubMedGoogle Scholar
• I-MOVE in Europe. Protocols/ Reviews 2014. Available from: https://sites.google.com/site/epiflu/docu [Last accessed 28 July 2014]
   Google Scholar
• Jacoby P, Kelly H. Is it necessary to adjust for calendar time in a test negative design?: responding to: Jackson ML, Nelson JC. The test negative design for estimating influenza vaccine effectiveness. Vaccine 2013;31(April (17)):2165-8. Vaccine 2014;32:2942
   PubMed Web of Science ®Google Scholar
• Greenland S. Invited commentary: variable selection versus shrinkage in the control of multiple confounders. Am J Epidemiol 2008;167:523-9. discussion 30-1
   PubMed Web of Science ®Google Scholar
• Cole SR, Chu H, Greenland S. Maximum likelihood, profile likelihood, and penalized likelihood: a primer. Am J Epidemiol 2014;179:252-60
   PubMed Web of Science ®Google Scholar
• Paneth N, Susser E, Susser M. Origins and early development of the case-control study: part 2, The case-control study from Lane-Claypon to 1950. Sozial- und Praventivmedizin 2002;47:359-65
   PubMedGoogle Scholar
• Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103:226-35
   PubMed Web of Science ®Google Scholar
• Knol MJ, Vandenbroucke JP, Scott P, Egger M. What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Am J Epidemiol 2008;168:1073-81
   PubMed Web of Science ®Google Scholar
• Rodrigues L, Kirkwood BR. Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol 1990;19:205-13
   PubMed Web of Science ®Google Scholar
• Andrews N, Waight PA, Borrow R, et al. Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales. PLoS One 2011;6:e28435
   PubMed Web of Science ®Google Scholar
• Broome CV, Facklam RR, Fraser DW. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 1980;303:549-52
   PubMed Web of Science ®Google Scholar
• Glymour M, Greenland S. Causal diagrams. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. 3rd edition. Lippincott, Williams & Wilkins; Philadelphia, PA, USA: 2008. p. 183-209
   Google Scholar
• I-MOVE. Conferences and workshops 2014. Available from: https://sites.google.com/site/epiflu/conferences [Last accessed 28 July 2014]
   Google Scholar
• WHO. International meeting on influenza vaccine effectiveness; WHO, Geneva, Switzerland; 2012. Available from: www.who.int/immunization/research/meetings_workshops/influenza_vaccine_effectiveness_dec12/en/ [Last accessed 28 July 2014]
   Google Scholar
• Jackson LA. Using surveillance to evaluate influenza vaccine effectiveness. J Infect Dis 2009;199:155-8
   PubMed Web of Science ®Google Scholar
• Irving SA, Donahue JG, Shay DK, et al. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine 2009;27:6546-9
   PubMed Web of Science ®Google Scholar
• Mangtani P, Shah A, Roberts JA. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect 2007;135:139-43
   PubMed Web of Science ®Google Scholar
• Mac Donald R, Baken L, Nelson A, Nichol KL. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999;16:173-7
   PubMed Web of Science ®Google Scholar
• Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol 1996;25:1107-16
   PubMed Web of Science ®Google Scholar
• Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977;105:488-95
   PubMed Web of Science ®Google Scholar
• Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:36-44
   PubMed Web of Science ®Google Scholar
• Druce JD, Tran T, Kelly H, et al. Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003. J Med Virol 2005;75:122-9
   PubMed Web of Science ®Google Scholar
• Ratcliff RM, Chang G, Kok T, Sloots TP. Molecular diagnosis of medical viruses. Curr Issues Mol Biol 2007;9:87-102
   PubMed Web of Science ®Google Scholar